CELC Celcuity LLC

USD 17.77 0.00 0
Icon

Celcuity LLC (CELC) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 17.77

0.00 (0.00)%

USD 0.58B

0.32M

USD 28.10(+58.13%)

USD 14.00 (-21.22%)

Icon

CELC

Celcuity LLC (USD)
COMMON STOCK | NSD
USD 17.77
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.58B

USD 14.00 (-21.22%)

USD 17.77

Celcuity LLC (CELC) Stock Forecast

Show ratings and price targets of :
USD 28.10
(+58.13%)

Based on the Celcuity LLC stock forecast from 4 analysts, the average analyst target price for Celcuity LLC is USD 28.10 over the next 12 months. Celcuity LLC’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Celcuity LLC is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Celcuity LLC’s stock price was USD 17.77. Celcuity LLC’s stock price has changed by +5.59% over the past week, +15.84% over the past month and +83.95% over the last year.

No recent analyst target price found for Celcuity LLC
No recent average analyst rating found for Celcuity LLC

Company Overview Celcuity LLC

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnorma...Read More

https://www.celcuity.com

16305?36th Avenue North, Minneapolis, MN, United States, 55446

55

December

USD

USA

Adjusted Closing Price for Celcuity LLC (CELC)

Loading...

Unadjusted Closing Price for Celcuity LLC (CELC)

Loading...

Share Trading Volume for Celcuity LLC Shares

Loading...

Compare Performance of Celcuity LLC Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for CELC

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Celcuity LLC (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD127.00B 31.94 20.00

ETFs Containing CELC

Symbol Name CELC's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Celcuity LLC (CELC) Stock

Based on ratings from 4 analysts Celcuity LLC's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 10 buy, sell and hold ratings.

Unfortunately we do not have enough data on CELC's stock to indicate if its a good dividend stock.

Based on targets from 4 analysts, the average taret price for CELC is USD 28.10 over the next 12 months. The maximum analyst target price is USD 40 while the minimum anlayst target price is USD 23.

Unfortunately we do not have enough data on CELC's stock to indicate if its overvalued.

The last closing price of CELC's stock was USD 17.77.

The most recent market capitalization for CELC is USD 0.58B.

Based on targets from 4 analysts, the average taret price for CELC is projected at USD 28.10 over the next 12 months. This means that CELC's stock price may go up by +58.13% over the next 12 months.

We can't find any ETFs which contains Celcuity LLC's stock.

As per our most recent records Celcuity LLC has 55 Employees.

Celcuity LLC's registered address is 16305?36th Avenue North, Minneapolis, MN, United States, 55446. You can get more information about it from Celcuity LLC's website at https://www.celcuity.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...